[ad_1]
“We’re actively in search of one other substantial spherical of funding to gasoline our growth,” stated Vivek Tiwari, co-founder and CEO of Medikabazaar, in an interview to ET. “We wish to elevate a big spherical of funding, within the vary of $150-200 million in six months,” Tiwari added.
If the proposed fundraise materialises, Medikabazaar will probably enter unicorn membership, or $1-billion valuation. Medikabazaar in April 2022 raised round $65 million from Lighthouse India Fund and different buyers. Based on startup information platform Tracxn, Medikabazaar was valued at $641 million within the final funding spherical.
Tiwari stated the funding would enable Medikabazaar to discover a spread of acquisition alternatives together with logistic corporations, fintechs, technological capabilities, specialty distribution firms, and white label merchandise.
In FY23, Medikabazaar achieved a gross merchandise worth (GMV) of round $536 million, leading to a web income of $70-80 million, equating to lower than 1% of whole GMV.
Tiwari stated Medikabazaar is sustaining breakeven. “There is no such thing as a evident money burn within the enterprise, permitting us to keep up a break-even or barely optimistic EBITDA.” Tiwari says he expects Medikabazaar to realize a minimum of 2-3% of the entire Indian healthcare medical provides market in subsequent 5 years, translating into GMV of over 5 occasions the present ranges.viswanath.pilla@timesgroup.com
[ad_2]
Source link